Sutro Biopharma Therapeutic Discovery and Technology
Sutro Biopharma (STRO) uses precise protein engineering and rational design for therapeutic discovery. The firm’s proprietary integrated cell-free protein synthesis platform known as XpressCF® and site-specific conjugation platform XpressCF+™ led to the discovery of the following:
- STRO-001 and STRO-002
This content is for paid subscribers.Today’s Highlights January 21, 2021
